Equity Compensation (Tables)

3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The amounts of equity-based compensation expense recognized as part of selling, general and administrative expenses were as follows (in thousands):

	For the Three Months Ended March 31,
	2017		2016
Restricted stock / units	$	442	$	1,641
Performance shares / units	214		113
Non-Qualified and performance stock options	182		335
Total stock-based compensation expense	$	838	$	2,089

Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]

As of March 31, 2017, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2013 Plan and previous plans, which is related to non-vested options and shares, was as follows (in thousands):

	March 31, 2017
Restricted stock and restricted stock units	$	13,549
Performance shares and performance share units	8,990
Non-Qualified and performance stock options	4,022
Total unrecognized stock-based compensation expense	$	26,561

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes information about stock option activity for the three months ended March 31, 2017:

	March 31, 2017				Weighted Average Exercise Price
Options outstanding at January 1, 2017	2,542,732				$	21.19
Granted	756,420				12.15
Exercised	—				—
Canceled	(30,725		)		20.46
Options outstanding at March 31, 2017	3,268,427				$	19.12
Options exercise price range at March 31, 2017	$	12.15		to	$	33.36
Options exercisable at March 31, 2017	2,546,100
Shares available for grant at March 31, 2017*	1,235,259

________

 * Shares available for grant as of March 31, 2017 reduced by net restricted stock and restricted stock unit award and performance share and performance share unit award activity of 2,657,112 shares and 2,127,934 shares, respectively.

Schedule of Share-based Compensation, Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2017:

	Options Outstanding				Options Exercisable
Exercise Prices	Number Outstanding At 3/31/17	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price		Number Exercisable At 3/31/17	Weighted Average Exercise Price
$ 12.15 – $20.00	1,441,916	7.0	$	13.09	735,339	$	14.12
$ 20.01 – $25.00	1,083,377	1.9	22.57		1,070,027	22.55
$ 25.01 – $30.00	738,638	1.7	25.55		736,238	25.55
$ 30.01 – $33.36	4,496	3.4	33.36		4,496	33.36
Total	3,268,427	4.8	$	19.12	2,546,100	$	21.24

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The fair value of options granted is estimated on the date of grant using a Black-Scholes option-pricing model. The calculated fair value of the 2017 performance option awards was $5.38 based on the following assumptions:

	2017
Expected dividend yield	0.4	%
Expected stock price volatility	39.1	%
Risk-free interest rate	2.31	%
Expected life in years	7.8
Forfeiture percentage	5.0	%

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

The following table summarizes information about restricted shares and restricted share units (primarily for non-U.S. recipients):

	March 31, 2017		Weighted Average Fair Value
Stock / Units unvested at  January 1, 2017	878,356		$	15.87
Granted	471,971		12.06
Vested	—		—
Canceled	(27,293	)	15.80
Stock / Units unvested at  March 31, 2017	1,323,034		$	14.51

Share-based Compensation, Performance Shares Award Unvested Activity [Table Text Block]

The following table summarizes information about performance shares and performance share units (for non-U.S. recipients):

	March 31, 2017	Weighted Average Fair Value
Shares / Units unvested at January 1, 2017	309,468	$	14.58
Granted	336,694	12.02
Vested	—	—
Canceled	—	—
Shares / Units unvested at March 31, 2017	646,162	$	13.25